Compiled Information for the Group 1 Extractables
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicoe | In Vitrod | |||||
A | B | ||||||||||||||
2,4-Dichlorobenzoic acid | 50-84-0 | 830 | LD50 | oral | mouse | 4 | 10 | 10 | 10 | 10 | 5.81 | 3 | Neg | Neg | Neg1 |
Glycerine | 56-81-5 | 4250 | LD50 | i.v. | mouse | 5 | 10 | 10 | 1 | 10 | 298 | 1 | Neg | Neg | Neg1a |
Palmitic Acid | 57-10-3 | 57 | LD50 | i.v. | mouse | 6 | 10 | 10 | 1 | 10 | 3.99 | 1 | Neg | Neg | Neg1 |
Stearic acid | 57-11-4 | 21.5 | LD50 | i.v. | rats | 7 | 10 | 10 | 1 | 10 | 1.51 | 1 | Neg | Neg | Neg1 |
Urea | 57-13-6 | 3000 | LDLO | i.v. | dog | 8 | 10 | 10 | 1 | 10 | 210 | 1 | Neg | Neg | Pos1a |
Propylene glycol | 57-55-6 | 4200 | LDLO | i.v. | rabbit | 9 | 10 | 10 | 1 | 10 | 294 | 1 | Neg | Neg | Neg1a |
Linoleic acid | 60-33-3 | 280 | LD50 | i.p. | mouse | 10 | 10 | 10 | 10 | 10 | 1.96 | 1 | Neg | Neg | Neg2 |
Formic acid | 64-18-6 | 2.57 | PDE | i.v. | human | 11 | 10 | 1 | 1 | 1 | 18.0 | 1 | Neg | Neg | Neg1 |
Acetic acid | 64-19-7 | 45.7 | PDE | i.v. | human | 11 | 10 | 1 | 1 | 1 | 320 | 1 | Neg | Neg | Neg1 |
Benzoic acid | 65-85-0 | 500 | LDLO | oral | human | 12 | 10 | 1 | 10 | 10 | 35.0 | 1 | Neg | Neg | Neg1a |
1700 | LD50 | i.v. | rats | 12 | 10 | 10 | 1 | 10 | 119 | ||||||
4.4 | EPA RfD | oral | human | 13 | 10 | 1 | 10 | 1 | 3.08 | ||||||
Hexanal | 66-25-1 | 4890 | LD50 | oral | rats | 14 | 10 | 10 | 10 | 10 | 34.2 | 1 | Pose | Neg | N/A |
Isopropanol | 67-63-0 | 1024 | LDLO | i.v. | dog | 15 | 10 | 10 | 1 | 10 | 71.9 | 1 | Neg | Neg | Neg1b |
Acetone | 67-64-1 | 3 | PDE | N/A | human | 11 | 10 | 1 | 1 | 1 | 21.0 | 1 | Neg | Neg | Neg1 |
Dimethylformamide | 68-12-2 | 470 | LD50 | i.v. | dog | 16 | 10 | 10 | 1 | 10 | 32.9 | 3 | Neg | Neg | Neg2b |
p-Toluenesulfonamide | 70-55-3 | 250 | LD50 | i.p. | mouse | 17 | 10 | 10 | 10 | 10 | 1.75 | 3 | Neg | Neg | N/A |
50 | NOEL | oral | rats | 18 | 10 | 10 | 10 | 1 | 3.50 | ||||||
1-Butanol | 71-36-3 | 310 | LD50 | i.v. | rats | 19 | 10 | 10 | 1 | 10 | 21.7 | 1 | Neg | Neg | Neg1 |
1-Pentanol | 71-41-0 | 15 | LDLO | i.v. | cats | 20 | 10 | 10 | 1 | 10 | 1.05 | 1 | Neg | Neg | N/A |
4-Chlorobenzoic acid | 74-11-3 | 1000 | LD50 | i.p. | rats | 21 | 10 | 10 | 10 | 10 | 7.00 | 3 | Neg | Posf | Neg1 |
Ethyl aldehyde | 75-07-0 | 10.6 | TDLO | i.v. | human | 22 | 10 | 1 | 1 | 10 | 7.42 | 1 | Pose | Neg | Neg1c |
Carbon disulfide | 75-15-0 | 7.6 | TDLO | i.p. | rats | 23 | 10 | 10 | 10 | 10 | 0.053 | 3 | Neg | Neg | N/A |
2,2-Dimethylpropanoic acid | 75-98-9 | 900 | LD50 | oral | rats | 24 | 10 | 10 | 10 | 10 | 6.30 | 1 | Neg | Neg | N/A |
Tributyl acetylcitrate | 77-90-7 | 4000 | LD50 | i.p. | mouse | 25 | 10 | 10 | 10 | 10 | 28.0 | 1 | Neg | Posg | Neg2 |
Diethoxydimethylsilane | 78-62-6 | 9280 | LD50 | oral | rats | 26 | 10 | 10 | 10 | 10 | 65.0 | 3 | Neg | Neg | Neg2 |
2-Butanone | 78-93-3 | 361 | TDLO | i.p. | rats | 27 | 10 | 10 | 10 | 10 | 2.53 | 1 | Neg | Neg | Neg2 |
Propionic acid | 79-09-4 | 625 | LD50 | i.v. | mouse | 28 | 10 | 10 | 1 | 10 | 43.8 | 1 | Neg | Neg | Neg1 |
Hydroxyacetic acid | 79-14-1 | 1000 | LD50 | i.v. | cat | 29 | 10 | 10 | 1 | 10 | 70.0 | 1 | Neg | Neg | Pos1 |
2-Hydroxypropanoic acid | 79-33-4 | 3194 | LD50 | i.p. | mouse | 30 | 10 | 10 | 10 | 10 | 22.4 | 1 | Neg | Neg | N/A |
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicoi | In Vitroh | |||||
A | B | ||||||||||||||
1,1,2,2-Tetrachloroethane | 79-34-5 | 50 | LDLO | i.v. | dog | 31 | 10 | 10 | 1 | 10 | 3.50 | 3 | Posj | Neg | Pos1c |
Bisphenol A | 80-05-7 | 5 | NOEL | oral | mouse | 32 | 10 | 10 | 10 | 1 | 0.35 | 3 | Neg | Neg | Neg1 |
4-tert-Amylphenol | 80-46-6 | 1830 | LD50 | oral | rats | 33 | 10 | 10 | 10 | 10 | 12.8 | 1 | Neg | Neg | Neg1 |
Methacrylic acid, methyl ester | 80-62-6 | 945 | LD50 | i.p. | mouse | 34 | 10 | 10 | 10 | 10 | 6.62 | 1 | Neg | Neg | Pos1b |
113 | LDLO | i.v. | dog | 35 | 10 | 10 | 1 | 10 | 7.91 | ||||||
Diethyl phthalate | 84-66-2 | 100 | LD50 | i.v. | rabbit | 36 | 10 | 10 | 1 | 10 | 7.00 | 1 | Neg | Posl | Neg1 |
Diisobutyl phthalate | 84-69-5 | 3990 | LD50 | i.p. | mouse | 37 | 10 | 10 | 10 | 10 | 27.9 | 1 | Neg | Posl | Neg1 |
Dibutyl phthalate | 84-74-2 | 720 | LD50 | i.v. | mouse | 38 | 10 | 10 | 1 | 10 | 50.4 | 1 | Neg | Posl | Neg1 |
Phthalic anhydride | 85-44-9 | 100 | LD50 | i.p. | guinea pig | 39 | 10 | 10 | 10 | 10 | 0.700 | 3 | Neg | Neg | Pos1b |
Benzyl butyl phthalate | 85-68-7 | 159 | NOAEL | oral | rats | 40 | 10 | 10 | 10 | 1 | 11.1 | 1 | Neg | Posl | Neg1d |
2-Furancarboxylic acid | 88-14-2 | 100 | LD50 | i.p. | mouse | 41 | 10 | 10 | 10 | 10 | 0.700 | 3 | Neg | Neg | Neg1 |
o-Toluenesulfonamide | 88-19-7 | 4870 | LD50 | oral | rats | 42 | 10 | 10 | 10 | 10 | 34.1 | 3 | Neg | Neg | Neg1e |
3,5-Di-tert-butyl-4-hydroxybenzyl alcohol | 88-26-6 | 7000 | LDLO | oral | rats | 43 | 10 | 10 | 10 | 10 | 49.0 | 2 | Neg | Neg | N/Aa |
175 | TDLO | oral | rats | 43 | 10 | 10 | 10 | 10 | 1.23 | ||||||
Phthalic acid | 88-99-3 | 250 | LD50 | i.p. | mouse | 44 | 10 | 10 | 10 | 10 | 1.75 | 1 | Neg | Posl | Neg1 |
102 | TDLO | oral | rats | 44 | 10 | 10 | 10 | 10 | 0.714 | ||||||
o-Hydroxybiphenyl | 90-43-7 | 100 | NOAEL | oral | rats | 45 | 10 | 10 | 10 | 1 | 7.00 | 3 | Neg | Posk | Pos2f |
α-Phenylbenzenemethanol | 91-01-0 | 5000 | LD50 | oral | rats | 46 | 10 | 10 | 10 | 10 | 35.0 | 3 | Neg | Neg | N/A |
Hexanoic acid, 2-ethyl-, diester with triethylene glycol | 94-28-0 | 13677 | LD50 | dermal | rabbit | 47 | 10 | 10 | 10 | 10 | 95.7 | 1 | Neg | Posm | N/A |
2-Ethyl-1,3-hexanediol | 94-96-2 | 131 | LD50 | i.v. | rats | 48 | 10 | 10 | 1 | 10 | 9.17 | 1 | Neg | Posm | Neg2 |
Benzothiazole | 95-16-9 | 95 | LD50 | i.v. | mouse | 49 | 10 | 10 | 1 | 10 | 6.65 | 3 | Neg | Neg | Neg1 |
o-Xylene | 95-47-6 | 1500 | LDLO | i.p. | mammal | 50 | 10 | 10 | 10 | 10 | 10.5 | 1 | Neg | Neg | Neg1 |
1,2,4-Trimethylbenzene | 95-63-6 | 1752 | LDLO | i.p. | rat | 51 | 10 | 10 | 10 | 10 | 12.3 | 1 | Neg | Neg | Neg1g |
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicoi | In Vitroh | |||||
A | B | ||||||||||||||
2,4-Di-t-butyl phenol | 96-76-4 | 100 | LD50 | i.v. | mouse | 52 | 10 | 10 | 1 | 10 | 7.00 | 1 | Neg | Neg | N/A |
25 | LD50 | i.p. | mouse | 52 | 10 | 10 | 10 | 10 | 0.175 | ||||||
1-Methylethylbenzene | 98-82-8 | 0.01 | PDE | N/A | human | 53 | 10 | 1 | 1 | 1 | 0.07 | 1 | Neg | Neg | Neg1 |
Acetophenone | 98-86-2 | 200 | LD50 | i.p. | mouse | 54 | 10 | 10 | 10 | 10 | 1.40 | 1 | Neg | Neg | Neg1 |
0.1 | EPA RfD | oral | human | 55 | 10 | 1 | 10 | 1 | 0.07 | ||||||
423 | NOAEL | oral | rats | 55 | 10 | 10 | 10 | 1 | 29.6 | ||||||
2-Propyl valeric acid | 99-66-1 | 20 | TDLO | i.v. | human | 56 | 10 | 10 | 1 | 1 | 14.0 | 1 | Neg | Posl | N/A |
Terephthalic acid | 100-21-0 | 767 | TDLO | i.v. | dogs | 57 | 10 | 10 | 1 | 10 | 53.7 | 1 | Neg | Neg | Neg1 |
Ethyl benzene | 100-41-4 | 1062 | TDLO | i.p. | rats | 58 | 10 | 10 | 10 | 10 | 7.43 | 1 | Neg | Neg | Pos1c |
Styrene | 100-42-5 | 0.28 | EPA RfC | inhaled | human | 59 | 10 | 1 | 1 | 1 | 1.96 | 1 | Neg | Neg | Neg2d |
4-Cyanocyclohexene | 100-45-8 | 460 | LD50 | oral | rats | 60 | 10 | 10 | 10 | 10 | 3.22 | 3 | Neg | Neg | N/A |
Benzyl alcohol | 100-51-6 | 50 | LDLO | i.v. | dog | 61 | 10 | 10 | 1 | 10 | 3.50 | 1 | Neg | Neg | Pos1b |
Benzaldehyde | 100-52-7 | 9 | LD50 | i.p. | mouse | 62 | 10 | 10 | 10 | 10 | 0.063 | 1 | Posj | Neg | Pos1e |
0.1 | EPA RfD | oral | human | 63 | 10 | 1 | 10 | 1 | 0.07 | ||||||
Diphenylmethane diisocyanate | 101-68-8 | 2200 | LD50 | oral | mouse | 64 | 10 | 10 | 10 | 10 | 15.4 | 3 | Posk | Neg | Pos1 |
Diphenyl ether | 101-84-8 | 2450 | LD50 | oral | rats | 65 | 10 | 10 | 10 | 10 | 17.2 | 3 | Neg | Neg | Neg1 |
301 | NOAEL | oral | rats | 66 | 10 | 10 | 10 | 1 | 21.1 | ||||||
2-Ethylhexyl acrylate | 103-11-7 | 1326 | LD50 | i.p. | mouse | 67 | 10 | 10 | 10 | 10 | 9.28 | 1 | Neg | Posl | Neg1 |
Bis(2-ethylhexyl)adipate | 103-23-1 | 540 | LD50 | i.v. | rabbit | 68 | 10 | 10 | 1 | 10 | 37.8 | 1 | Neg | Posl | Neg1f |
Dibenzyl amine | 103-49-1 | 395 | LD50 | oral | rats | 69 | 10 | 10 | 10 | 10 | 2.77 | 3 | Neg | Neg | N/A |
Dihydro-5-pentyl-2(3H)-furanone | 104-61-0 | 3440 | LD50 | oral | guinea pig | 70 | 10 | 10 | 10 | 10 | 24.1 | 2 | Neg | Neg | N/A |
2-Ethyl-1-hexanol | 104-76-7 | 500 | LD50 | i.p. | rats | 71 | 10 | 10 | 10 | 10 | 3.50 | 1 | Neg | Posl | Neg1g |
50 | NOAEL | oral | rats | 72, 73 | 10 | 10 | 10 | 1 | 3.50 | ||||||
p-Methylbenzaldehyde | 104-87-0 | 400 | LD50 | i.p. | mouse | 74 | 10 | 10 | 10 | 10 | 2.80 | 1 | Posj | Neg | Neg1 |
1,4-Cyclohexanedimethanol | 105-08-8 | 800 | LDLO | i.p. | rats | 75 | 10 | 10 | 10 | 10 | 5.60 | 1 | Neg | Neg | N/A |
1,1-Diethoxyethane | 105-57-7 | 500 | LD50 | i.p. | mouse | 76 | 10 | 10 | 10 | 10 | 3.50 | 1 | Neg | Neg | Pos1 |
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicog | In Vitrof | |||||
A | B | ||||||||||||||
Caprolactam | 105-60-2 | 300 | LD | i.v. | rabbit | 77 | 10 | 10 | 1 | 10 | 21.0 | 3 | Neg | Neg | Neg2b |
3-Heptanone | 106-35-4 | 2760 | LD50 | oral | rats | 78 | 10 | 10 | 10 | 10 | 19.3 | 2 | Neg | Neg | N/A |
p-Xylene | 106-42-3 | 2000 | LDLO | i.p. | mammal | 79 | 10 | 10 | 10 | 10 | 14.0 | 1 | Neg | Neg | Neg1 |
Acrylonitrile | 107-13-1 | 0.00004 | EPA RfC | inhaled | human | 80 | 10 | 1 | 1 | 1 | 0.001 | 3 | Neg | Neg | Pos1c |
Ethylene glycol | 107-21-1 | 0.09 | PDE | N/A | human | 81 | 10 | 1 | 1 | 1 | 0.63 | 1 | Neg | Neg | Neg2b |
3-Methyl-2-butenal | 107-86-8 | 378 | LD50 | i.p. | mouse | 82 | 10 | 10 | 10 | 10 | 2.65 | 1 | Posi | Neg | N/A |
Butyric acid | 107-92-6 | 500 | LDLO | oral | mouse | 83 | 10 | 10 | 10 | 10 | 3.50 | 1 | Neg | Neg | Neg1 |
Methyisobutylketone | 108-10-1 | 1.43 | PDE | N/A | human | 11 | 10 | 1 | 1 | 1 | 10.0 | 1 | Neg | Neg | Pos1 |
3,5-Dimethylphenol | 108-68-9 | 156 | LD50 | i.p. | mouse | 84 | 10 | 10 | 10 | 10 | 1.09 | 1 | Neg | Neg | Neg1 |
Toluene | 108-88-3 | 0.08 | EPA RfD | oral | human | 85 | 10 | 1 | 10 | 1 | 0.056 | 1 | Neg | Neg | Neg1 |
0.127 | PDE | N/A | human | 81 | 10 | 1 | 1 | 1 | 0.89 | ||||||
Cyclohexanol | 108-93-0 | 272 | LD50 | i.v. | mouse | 86 | 10 | 10 | 1 | 10 | 19.0 | 2 | Neg | Neg | Neg1 |
Cyclohexanone | 108-94-1 | 100 | NOEL | i.v. | rats | 87 | 10 | 10 | 1 | 1 | 70.0 | 2 | Neg | Neg | Pos1b |
Phenol | 108-95-2 | 112 | LD50 | i.v. | mouse | 88 | 10 | 10 | 1 | 10 | 7.84 | 1 | Neg | Neg | Pos1b |
0.3 | EPA RfD | oral | human | 89 | 10 | 1 | 10 | 1 | 0.21 | ||||||
3-Hydroxypyridine | 109-00-2 | 200 | TDLO | i.p. | mouse | 90 | 10 | 10 | 10 | 10 | 1.40 | 3 | Neg | Neg | N/A |
Butanoic acid, butyl ester | 109-21-7 | 2300 | LD50 | i.p. | rats | 91 | 10 | 10 | 10 | 10 | 16.1 | 1 | Neg | Neg | Neg1 |
Pentanoic acid | 109-52-4 | 1290 | LD50 | i.v. | mouse | 92 | 10 | 10 | 1 | 10 | 90.3 | 1 | Neg | Neg | N/A |
Tetrahydrofuran | 109-99-9 | 7.2 | PDE | N/A | human | 93 | 10 | 1 | 1 | 1 | 50.4 | 3 | Neg | Neg | Neg1e |
Succinic acid | 110-15-6 | 1.5 | TDLO | oral | mouse | 94 | 10 | 10 | 10 | 10 | 0.011 | 1 | Neg | Neg | N/A |
1400 | LD50 | i.v. | mouse | 94 | 10 | 10 | 1 | 10 | 98.0 | ||||||
Pentanal | 110-62-3 | 5.66 | LD50 | oral | rats | 95 | 10 | 10 | 10 | 10 | 0.040 | 1 | Posh | Neg | Pos1 |
Tetramethylene glycol | 110-63-4 | 10 | TDLO | oral | human | 96 | 10 | 1 | 10 | 10 | 0.70 | 1 | Neg | Neg | Neg1 |
2-Ethoxyethanol | 110-80-5 | 143 | TDLO | oral | human | 97 | 10 | 1 | 10 | 10 | 10.0 | 1 | Neg | Neg | Neg1 |
900 | LD50 | i.v. | rabbit | 97 | 10 | 10 | 1 | 10 | 63.0 | ||||||
Pyridine | 110-86-1 | 1.0 | NOAEL | oral | rats | 98 | 1 | 10 | 10 | 10 | 0.07 | 3 | Neg | Neg | Neg2j |
Piperidine | 110-89-4 | 160 | TDLO | i.v. | rabbit | 99 | 10 | 10 | 1 | 10 | 11.2 | 3 | Neg | Neg | Pos1b |
300 | TDLO | i.v. | rabbit | 99 | 10 | 10 | 1 | 10 | 21.0 | ||||||
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicog | In Vitrof | |||||
A | B | ||||||||||||||
Pentanedioic acid | 110-94-1 | 2750 | LD50 | oral | rats | 100 | 10 | 10 | 10 | 10 | 19.3 | 1 | Neg | Neg | N/A |
Squalene | 111-02-4 | 1800 | LD50 | i.v. | mouse | 101 | 10 | 10 | 1 | 10 | 126 | 1 | Neg | Neg | Neg1 |
2-Octanone | 111-13-7 | 800 | LD50 | i.p. | mouse | 102 | 10 | 10 | 10 | 10 | 5.60 | 2 | Neg | Neg | N/A |
Heptanoic acid | 111-14-8 | 1200 | LD50 | i.v. | mouse | 103 | 10 | 10 | 1 | 10 | 84.0 | 1 | Neg | Neg | Neg1 |
Sebacic acid | 111-20-6 | 500 | LD50 | i.p. | mouse | 104 | 10 | 10 | 10 | 10 | 3.50 | 1 | Neg | Neg | Neg1 |
1-Hexanol | 111-27-3 | 103 | LD50 | i.v. | mouse | 105 | 10 | 10 | 1 | 10 | 7.21 | 1 | Neg | Neg | N/A |
Diethylene glycol | 111-46-6 | 2236 | TDLO | i.v. | rabbit | 106 | 10 | 10 | 1 | 10 | 157 | 1 | Neg | Neg | Neg1d |
Octdecanoic acid, 2-hydroethyl ester | 111-60-4 | 200 | LD50 | i.p. | mouse | 107 | 10 | 10 | 10 | 10 | 1.40 | 1 | Neg | Neg | N/A |
Octadecanoic acid, ethyl ester | 111-61-5 | 5000 | LD50 | oral | rats | 108 | 10 | 10 | 10 | 10 | 35.0 | 1 | Neg | Neg | N/A |
Octadecenoic acid, ethyl ester | 111-62-6 | 5000 | LD50 | oral | rats | 109 | 10 | 10 | 10 | 10 | 35.0 | 1 | Neg | Neg | N/A |
1-Heptanol | 111-70-6 | 256 | TDLO | i.p. | rats | 110 | 10 | 10 | 10 | 10 | 1.79 | 1 | Neg | Neg | N/A |
2-(1-Butoxy) ethanol | 111-76-2 | 252 | LD50 | i.v. | rabbit | 111 | 10 | 10 | 1 | 10 | 17.6 | 1 | Neg | Neg | Neg1e |
Octanol | 111-87-5 | 69 | LD50 | i.v. | mouse | 112 | 10 | 10 | 1 | 10 | 4.83 | 1 | Neg | Neg | Neg1 |
Ethylethoxyethanol | 111-90-0 | 1000 | LDLO | i.v. | cat | 113 | 10 | 10 | 1 | 10 | 70.0 | 1 | Neg | Neg | N/A |
167 | NOEL | oral | pigs | 114 | 10 | 10 | 10 | 1 | 11.7 | ||||||
Dibutyl amine | 111-92-2 | 110 | LD50 | i.p. | rats | 115 | 10 | 10 | 10 | 10 | 0.77 | 3 | Neg | Neg | N/A |
Nonanoic acid | 112-05-0 | 224 | LD50 | i.v. | mouse | 116 | 10 | 10 | 1 | 10 | 15.7 | 1 | Neg | Neg | N/A |
2-(2-Ethoxyethoxy) ethyl acetate | 112-15-2 | 4400 | LD50 | oral | rabbit | 117 | 10 | 10 | 10 | 10 | 30.8 | 1 | Neg | Neg | N/A |
Triethylene glycol | 112-27-6 | 1900 | LD50 | i.v. | rabbit | 118 | 10 | 10 | 1 | 10 | 133 | 1 | Neg | Neg | Neg1b |
2-(2-Butoxyethoxy)ethanol | 112-34-5 | 850 | LD50 | i.p. | mouse | 119 | 10 | 10 | 10 | 10 | 5.95 | 1 | Neg | Neg | Pos1 |
Undecanoic acid | 112-37-8 | 140 | LD50 | i.v. | mouse | 120 | 10 | 10 | 1 | 10 | 9.80 | 1 | Neg | Neg | N/A |
Hexadecanoic acid, methyl ester | 112-39-0 | 750 | TDLO | i.v. | mouse | 121 | 10 | 10 | 1 | 10 | 52.5 | 1 | Neg | Neg | N/A |
1-Dodecene | 112-41-4 | 10000 | TDLO | oral | mouse | 122 | 10 | 10 | 10 | 10 | 70.0 | 1 | Neg | Neg | N/A |
Dodecanol | 112-53-8 | 390 | LD50 | i.v. | rats | 123 | 10 | 10 | 1 | 10 | 27.3 | 1 | Neg | Neg | Neg1 |
8000 | TDLO | subq | guinea pig | 123 | 10 | 10 | 10 | 10 | 56.0 | ||||||
100 | NOAEL | oral | rats | 124 | 10 | 10 | 10 | 1 | 7.00 | ||||||
Dodecanal | 112-54-9 | 23000 | LD50 | oral | rats | 125 | 10 | 10 | 10 | 10 | 161 | 1 | Posh | Neg | N/A |
Tetraethylene glycol | 112-60-7 | 200 | TDLO | oral | rats | 126 | 10 | 10 | 10 | 10 | 1.40 | 1 | Neg | Neg | N/A |
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicoe | In Vitrod | |||||
A | B | ||||||||||||||
Octadecenoic acid, methyl ester | 112-62-9 | 2000 | LD50 | oral | rats | 127 | 10 | 10 | 10 | 10 | 14.0 | 1 | Neg | Neg | N/A |
Tetradecanol | 112-72-1 | 5000 | LD50 | oral | rats | 128 | 10 | 10 | 10 | 10 | 35.0 | 1 | Neg | Neg | N/A |
Oleic acid | 112-80-1 | 0.08 | TDLO | i.v. | monkey | 129 | 10 | 10 | 1 | 10 | 0.006 | 1 | Neg | Neg | Neg1 |
100 | TDLO | i.v. | rats | 129 | 10 | 10 | 1 | 10 | 7.00 | ||||||
Erucamide | 112-84-5 | 5000 | LD50 | oral | rats | 130 | 10 | 10 | 10 | 10 | 35.0 | 3 | Neg | Neg | Neg1 |
7500 | NOAEL | oral | rats | 130 | 10 | 10 | 10 | 1 | 525 | ||||||
Oleonitrile | 112-91-4 | 5000 | LD50 | oral | rats | 131 | 10 | 10 | 10 | 10 | 35.0 | 3 | Neg | Neg | N/A |
Octadecanol | 112-92-5 | 2000 | LD50 | oral | rats | 132 | 10 | 10 | 10 | 10 | 14.0 | 1 | Neg | Neg | Neg1 |
Triphenylphosphate | 115-86-6 | 300 | TDLO | subcu | cat | 133 | 10 | 10 | 10 | 10 | 2.10 | 3 | Neg | Neg | Neg1 |
Bis-(2-ethylhexyl) phthalate | 117-81-7 | 60 | NOAEL | N/A | rats | 134 | 10 | 10 | 1 | 1 | 42.0 | 1 | Neg | Posg | Pos1c |
Octyldecyl phthalate | 119-07-3 | 44070 | LD50 | oral | rats | 135 | 10 | 10 | 10 | 10 | 308 | 1 | Neg | Posh | N/A |
Benzophenone | 119-61-9 | 20 | NOAEL | oral | rats | 136 | 10 | 10 | 10 | 1 | 1.40 | 3 | Neg | Neg | Neg2 |
9,10-Dihydroxystearic acid | 120-87-6 | 178 | LD50 | i.v. | rats | 137 | 10 | 10 | 1 | 10 | 12.5 | 2 | Neg | Neg | N/A |
1000 | NOAEL | oral | rats | 137 | 10 | 10 | 10 | 1 | 70.0 | ||||||
4-Hydroxy-3-methoxybenzoic acid | 121-34-6 | 2691 | LD50 | i.p. | mouse | 138 | 10 | 10 | 10 | 10 | 18.8 | 1 | Neg | Neg | N/A |
1,3-Benzenedicarboxylic acid | 121-91-5 | 4200 | LD50 | i.p. | mouse | 139 | 10 | 10 | 10 | 10 | 29.4 | 1 | Neg | Neg | Neg1 |
Triisopropanolamine | 122-20-3 | 2520 | LD50 | oral | mouse | 140 | 10 | 10 | 10 | 10 | 17.6 | 1 | Neg | Neg | Neg1b |
272 | NOAEL | oral | dog | 141 | 10 | 10 | 10 | 1 | 19.0 | ||||||
2-Ethyl-1-hexanal | 123-05-7 | 500 | LD50 | i.p. | rats | 142 | 10 | 10 | 10 | 10 | 3.50 | 1 | Posf | Neg | Neg1 |
Nonanoic acid, ethyl ester | 123-29-5 | 24000 | LD50 | oral | guinea pig | 143 | 10 | 10 | 10 | 10 | 168 | 1 | Neg | Neg | N/A |
Azelaic acid | 123-99-9 | 5000 | LD50 | oral | rats | 144 | 10 | 10 | 10 | 10 | 35.0 | 1 | Neg | Neg | N/A |
Adipic acid | 124-04-9 | 680 | LD50 | i.v. | mouse | 145 | 10 | 10 | 1 | 10 | 47.6 | 1 | Neg | Posh | Neg2 |
Octanoic acid | 124-07-2 | 600 | LD50 | i.v. | mouse | 146 | 10 | 10 | 1 | 10 | 42.0 | 1 | Neg | Neg | Neg1 |
Tetradecanoic acid, ethyl ester | 124-10-7 | 2000 | LD50 | oral | rats | 147 | 10 | 10 | 10 | 10 | 14.0 | 1 | Neg | Neg | N/A |
Octanal | 124-13-0 | 60 | LD50 | i.v. | mouse | 148 | 10 | 10 | 1 | 10 | 4.20 | 1 | Posf | Neg | N/A |
Nonanal | 124-19-6 | 5000 | LD50 | oral | rats | 149 | 10 | 10 | 10 | 10 | 35.0 | 1 | Posf | Neg | Neg2 |
Octadecanamide | 124-26-5 | 10000 | LD50 | oral | rats | 150 | 10 | 10 | 10 | 10 | 70.0 | 3 | Neg | Neg | Neg1 |
Stearylamine | 124-30-1 | 3 | NOAEL | oral | dog | 151 | 10 | 10 | 10 | 1 | 0.21 | 1 | Neg | Neg | Neg1 |
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicog | In Vitrod | |||||
A | B | ||||||||||||||
Neopentyl glycol | 126-30-7 | 3200 | LD50 | oral | rats | 152 | 10 | 10 | 10 | 10 | 22.4 | 1 | Neg | Neg | Neg1 |
Tributyl phosphate | 126-73-8 | 100 | LDLO | i.v. | rats | 153 | 10 | 10 | 1 | 10 | 7.00 | 3 | Posi | Neg | Neg1c |
2,4,7,9-Tetramethyl-5-decyn-4,7-diol | 126-86-3 | 500 | LD50 | oral | rats | 154 | 10 | 10 | 10 | 10 | 3.50 | 3 | Neg | Neg | N/A |
Diphenyl sulfone | 127-63-9 | 320 | LD50 | i.v. | mouse | 155 | 10 | 10 | 1 | 10 | 22.4 | 3 | Neg | Neg | N/A |
2,6-Di-t-butyl-4-methyl phenol (BHT) | 128-37-0 | 180 | LD50 | i.v. | mouse | 156 | 10 | 10 | 1 | 10 | 12.6 | 2 | Neg | Neg | Neg1d |
650 | LD50 | Subq | mouse | 156 | 10 | 10 | 10 | 10 | 4.55 | ||||||
0.596 | PEL | inhaled | human | 157 | 10 | 10 | 1 | 1 | 0.417 | ||||||
25 | NOAEL | oral | rats | 158 | 10 | 10 | 10 | 1 | 1.75 | ||||||
2,6-Di-tert-butylphenol | 128-39-2 | 10 | LDLO | i.v. | rabbit | 159 | 10 | 10 | 1 | 10 | 0.700 | 2 | Neg | Neg | N/A |
1,2-Benzenecarboxylic acid, monobutyl ester | 131-70-4 | 400 | TDLO | oral | mouse | 160 | 10 | 10 | 10 | 10 | 2.80 | 1 | Neg | Posj | N/A |
Tetramethylbutyl phenol | 140-66-9 | 5 | TDLO | i.p. | mouse | 161 | 10 | 10 | 10 | 10 | 0.035 | 1 | Neg | Neg | Neg1 |
2-Ethylhexyl fumarate | 141-02-6 | 250 | LD50 | i.p. | mouse | 162 | 10 | 10 | 10 | 10 | 1.75 | 1 | Neg | Posk | N/A |
Ricinoleic acid | 141-22-0 | 10000 | LD50 | oral | rats | 163 | 10 | 10 | 10 | 10 | 70.0 | 2 | Neg | Neg | Neg1 |
Decamethyltetrasiloxane | 141-62-8 | 25 | NOEL | oral | rats | 164 | 10 | 10 | 10 | 1 | 1.75 | 3 | Neg | Neg | N/A |
1,1,1,5,5,5-Hexamethyl-3,3-bisoxytrisiloxane | 141-63-9 | 50000 | LDLO | oral | guinea pig | 165 | 10 | 10 | 10 | 10 | 350 | 3 | Neg | Neg | N/A |
Ethyl acetate | 141-78-6 | 709 | LD50 | i.p. | mouse | 166 | 10 | 10 | 10 | 10 | 4.96 | 1 | Neg | Neg | Neg1 |
Hexanoic acid | 142-62-1 | 1725 | LD50 | i.v. | mouse | 167 | 10 | 10 | 1 | 10 | 121 | 1 | Neg | Neg | Neg1 |
Dodecanoic acid | 143-07-7 | 131 | LD50 | i.v. | mouse | 168 | 10 | 10 | 1 | 10 | 9.17 | 1 | Neg | Neg | Neg1 |
Nonanol | 143-08-8 | 800 | LD50 | i.p. | mouse | 169 | 10 | 10 | 10 | 10 | 5.60 | 1 | Neg | Neg | N/A |
2-Mercaptobenzothiazole | 149-30-4 | 100 | LD50 | oral | rats | 170 | 10 | 10 | 10 | 10 | 0.700 | 3 | Neg | Neg | Pos1l |
2-Ethylhexanoic acid | 149-57-5 | 270 | LD50 | i.p. | mouse | 171 | 10 | 10 | 10 | 10 | 1.89 | 1 | Neg | Neg | Neg1 |
61 | NOAEL | oral | rats | 172 | 10 | 10 | 10 | 1 | 4.27 | ||||||
25 | NOAEL | oral | rabbit | 173 | 10 | 10 | 10 | 1 | 1.75 | ||||||
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicof | In Vitroe | |||||
A | B | ||||||||||||||
4-Methoxyphenol | 150-76-5 | 200 | TDLO | i.p. | mouse | 174 | 10 | 10 | 10 | 10 | 1.40 | 1 | Neg | Neg | Neg1c |
Cyclohexene oxide | 286-20-4 | 549 | LD50 | i.p. | rats | 175 | 10 | 10 | 10 | 10 | 3.84 | 3 | Posg | Neg | Pos2 |
Oleamide | 301-02-0 | 5 | TDLO | i.p. | rats | 176 | 10 | 10 | 10 | 10 | 0.035 | 3 | Neg | Neg | Neg1 |
Decanoic acid | 334-48-5 | 129 | LD50 | i.v. | mouse | 177 | 10 | 10 | 1 | 10 | 9.03 | 1 | Neg | Neg | Neg1 |
3,5-Dimethylbenzoic acid | 499-06-9 | 750 | LD50 | i.p. | mouse | 178 | 10 | 10 | 10 | 10 | 5.25 | 1 | Neg | Neg | N/A |
Caprolactone | 502-44-3 | 1300 | LD50 | i.p. | mouse | 179 | 10 | 10 | 10 | 10 | 9.10 | 1 | Neg | Neg | N/A |
3-Methylbutanoic acid | 503-74-2 | 1120 | LD50 | i.v. | mouse | 180 | 10 | 10 | 1 | 10 | 21.7 | 1 | Neg | Neg | N/A |
Heptadecanoic acid (Margaric acid) | 506-12-7 | 36 | LD50 | i.v. | mouse | 181 | 10 | 10 | 1 | 10 | 2.52 | 1 | Neg | Neg | N/A |
Abietic acid | 514-10-3 | 180 | LD50 | i.v. | mouse | 182 | 10 | 10 | 1 | 10 | 12.6 | 3 | Neg | Neg | Neg2 |
2-Chloroacetophenone | 532-27-4 | 30 | LD50 | i.v. | rabbit | 183 | 10 | 10 | 1 | 10 | 2.10 | 3 | Posh | Neg | Neg1b |
Decamethylcyclopentasiloxane | 541-02-6 | 24134 | LD50 | oral | rats | 184 | 10 | 10 | 10 | 10 | 169 | 3 | Neg | Neg | Neg2 |
Myristic acid | 544-63-8 | 43 | LD50 | i.v. | mouse | 185 | 10 | 10 | 1 | 10 | 3.01 | 1 | Neg | Neg | Neg1 |
Octamethylcyclotetrasiloxane | 556-67-2 | 100 | TDLO | N/A | mouse | 186 | 10 | 10 | 10 | 10 | 0.70 | 3 | Neg | Neg | Neg2 |
5-Quinolinol | 578-67-6 | 0.00086 | TTC | N/A | human | 187 | 10 | 1 | 1 | 1 | 0.006 | 3 | Neg | Neg | Neg1 |
2-Methyl cyclohexanol | 583-59-5 | 1000 | LD50 | i.m. | mouse | 188 | 10 | 10 | 10 | 10 | 7.00 | 2 | Neg | Neg | N/A |
3-Heptanol | 589-82-2 | 180 | TDLO | i.p. | rats | 189 | 10 | 10 | 10 | 10 | 1.26 | 2 | Neg | Neg | N/A |
Propanoic acid, butyl ester | 590-01-2 | 5000 | LD50 | oral | rats | 190 | 10 | 10 | 10 | 10 | 35.0 | 1 | Neg | Neg | N/A |
2-Pyrrolidinone | 616-45-5 | 800 | LDLO | i.v. | rabbit | 191 | 10 | 10 | 1 | 10 | 56.0 | 3 | Neg | Neg | N/A |
α-α-Dimethylbenzenemethanol | 617-94-7 | 1300 | LD50 | oral | rats | 192 | 10 | 10 | 10 | 10 | 9.10 | 3 | Neg | Neg | N/A |
m-Methylbenzaldehyde | 620-23-5 | 1600 | LD50 | oral | rat | 193 | 10 | 10 | 10 | 10 | 11.2 | 1 | Posi | Neg | N/A |
Hexanedioic acid, dimethyl ester | 627-93-0 | 1809 | LD50 | i.p. | rats | 194 | 10 | 10 | 10 | 10 | 12.7 | 1 | Neg | Posj | N/A |
1,6-Hexanediol | 629-11-8 | 1000 | NOAEL | oral | rats | 195 | 10 | 10 | 10 | 1 | 70 | 1 | Neg | Neg | Neg1 |
Isophthalic acid, diethyl ester | 636-09-9 | 1111 | LDLO | i.p. | mouse | 196 | 10 | 10 | 10 | 10 | 7.78 | 1 | Neg | Neg | N/A |
Diethyl isophthalate | 636-53-3 | 1111 | LDLO | i.p. | mouse | 197 | 10 | 10 | 10 | 10 | 7.78 | 1 | Neg | Neg | N/A |
2,6-Di-tert-butyl-p-benzoquinone | 719-22-2 | 2270 | LD50 | i.p. | mouse | 198 | 10 | 10 | 10 | 10 | 15.9 | 2 | Posc | Neg | N/A |
1-Cyclohexyl-2-ethanone | 823-76-7 | 6800 | LD50 | oral | mouse | 199 | 10 | 10 | 10 | 10 | 47.6 | 1 | Neg | Neg | N/A |
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicob | In Vitroa | |||||
A | B | ||||||||||||||
1-Methyl-2-pyrrolidinone | 872-50-4 | 54.5 | LD50 | i.v. | mouse | 200 | 10 | 10 | 1 | 10 | 3.82 | 3 | Neg | Neg | Neg1d |
2-Cyclohexene-1-one | 930-68-7 | 70 | LD50 | dermal | rabbit | 201 | 10 | 10 | 10 | 10 | 0.49 | 2 | Posd | Neg | N/A |
Diphenylsilanediol | 947-42-2 | 180 | LD50 | i.v. | mouse | 203 | 10 | 10 | 1 | 10 | 12.6 | 3 | Neg | Neg | N/A |
Pentadecanoic acid | 1002-84-2 | 54 | LD50 | i.v. | mouse | 202 | 10 | 10 | 1 | 10 | 3.78 | 1 | Neg | Neg | N/A |
1,1'-Carbonothiobis-piperidine | 1013-92-9 | 500 | LDLO | i.p. | mouse | 204 | 10 | 10 | 10 | 10 | 3.50 | 3 | Neg | Posi | N/A |
Trimethylsilanol | 1066-40-6 | 160 | NOEL | oral | rats | 205 | 10 | 10 | 10 | 1 | 11.2 | 3 | Neg | Neg | Neg2 |
1,1,3,3-Tetramethyl-1,3-disiloxanediol | 1118-15-6 | 1500 | TDLO | oral | rats | 206 | 10 | 10 | 10 | 10 | 10.5 | 3 | Neg | Neg | N/A |
Pentanedioic acid, dimethyl ester | 1119-40-0 | 6400 | LD50 | oral | rats | 207 | 10 | 10 | 10 | 10 | 44.8 | 1 | Neg | Neg | N/A |
3,5-Di-t-butyl-4-hydroxybenzaldehyde | 1620-98-0 | 1000 | LD50 | i.p. | mouse | 208 | 10 | 10 | 10 | 10 | 7.00 | 2 | Pose | Neg | N/A |
968 | LDLO | oral | rats | 208 | 10 | 10 | 10 | 10 | 6.78 | ||||||
3,3'-Oxybispropanenitrile | 1656-48-0 | 2830 | TD50 | oral | rats | 209 | 10 | 10 | 10 | 10 | 19.8 | 3 | Neg | Neg | N/A |
Dehydroabietic acid | 1740-19-8 | 1710 | LD50 | oral | rats | 210 | 10 | 10 | 10 | 10 | 12.0 | 2 | Neg | Neg | N/A |
Irganox 1076 | 2082-79-3 | 1000 | LD50 | i.p. | rats | 211 | 10 | 10 | 10 | 10 | 7.00 | 2 | Neg | Neg | N/A |
Lauryl acrylate | 2156-97-0 | 3590 | LD50 | i.p. | mouse | 212 | 10 | 10 | 10 | 10 | 25.1 | 1 | Neg | Neg | N/A |
Vinyl caprolacam | 2235-00-9 | 16.7 | NOAEL | inhaled | rats | 213 | 10 | 10 | 10 | 1 | 1.17 | 3 | Neg | Neg | N/A |
Monoethyl phthalate | 2306-33-4 | 700 | LD50 | i.p. | mouse | 214 | 10 | 10 | 10 | 10 | 4.90 | 3 | Neg | Posf | N/A |
Drometrizole | 2440-22-4 | 6500 | LD50 | oral | mouse | 215 | 10 | 10 | 10 | 10 | 45.5 | 3 | Neg | Neg | N/A |
9,10-Epoxy stearic acid | 2443-39-2 | 250 | LD50 | oral | rats | 216 | 10 | 10 | 10 | 10 | 1.75 | 3 | Posg | Neg | N/A |
3-Methyl-1,3-bis(hydroxy)butane | 2568-33-4 | 5000 | LD50 | oral | rats | 217 | 10 | 10 | 10 | 10 | 35.0 | 3 | Neg | Neg | N/A |
1-Piperidinecarboxaldehyde | 2591-86-8 | 300 | LDLO | i.v. | rabbit | 218 | 10 | 10 | 1 | 10 | 21.0 | 3 | Neg | Neg | N/A |
Hexaethylene glycol | 2615-15-8 | 32000 | LD50 | oral | rats | 219 | 10 | 10 | 10 | 10 | 224 | 3 | Neg | Neg | N/A |
Dihydrogenmonolauryl phosphate | 2627-35-2 | 6700 | LD50 | oral | rats | 220 | 10 | 10 | 10 | 10 | 46.9 | 1 | Neg | Neg | N/A |
Tris(2-ethylhexyl trimellitate) | 3319-31-1 | 2000 | LD50 | oral | rats | 221 | 10 | 10 | 10 | 10 | 14.0 | 1 | Neg | Posh | Neg1 |
654 | NOAEL | oral | rats | 222 | 10 | 10 | 10 | 1 | 45.8 | ||||||
Nonaethylene glycol | 3386-18-3 | 37000 | LD50 | oral | rats | 223 | 10 | 10 | 10 | 10 | 259 | 3 | Neg | Neg | N/A |
N-Butyl-benzenesulfonamide | 3622-84-2 | 50 | NOAEL | oral | rats | 224 | 10 | 10 | 10 | 1 | 3.50 | 3 | Neg | Neg | N/A |
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicob | In Vitroa | |||||
A | B | ||||||||||||||
2-Pentyl furan | 3777-96-3 | 1200 | LD50 | oral | mouse | 225 | 10 | 10 | 10 | 10 | 8.40 | 3 | Neg | Neg | N/A |
2-Butyl-1-octanol | 3913-02-8 | 13000 | LD50 | oral | rats | 226 | 10 | 10 | 10 | 10 | 91.0 | 1 | Neg | Posc | N/A |
Isophorone diisocyanate | 4098-71-9 | 4825 | LD50 | oral | rats | 227 | 10 | 10 | 10 | 10 | 33.8 | 3 | Posd | Neg | Neg1 |
Hexadecanoic acid, 2-hydroxyethyl ester | 4219-49-2 | 3000 | LD50 | i.p. | mouse | 228 | 10 | 10 | 10 | 10 | 21.0 | 1 | Neg | Neg | N/A |
6-Chlorohexanoic acid | 4224-62-8 | 3080 | LD50 | oral | rats | 229 | 10 | 10 | 10 | 10 | 21.6 | 3 | Pose | Neg | N/A |
Mono-(2-ethylhexyl) phthalate | 4376-20-9 | 150 | LD50 | i.v. | rats | 230 | 10 | 10 | 1 | 10 | 10.5 | 1 | Neg | Posf | Neg1 |
1,4-Dioxacyclotridecane-5,13-dione | 4471-27-6 | 7940 | LDLO | dermal | rabbit | 231 | 10 | 10 | 10 | 10 | 55.6 | 1 | Neg | Neg | N/A |
Pentaethylene glycol | 4792-15-8 | 5000 | LD50 | i.p. | rats | 232 | 10 | 10 | 10 | 10 | 35.0 | 1 | Neg | Neg | N/A |
Cyclohexaneacetic acid | 5292-21-7 | 178 | LD50 | i.v. | mouse | 233 | 10 | 10 | 1 | 10 | 12.5 | 1 | Neg | Neg | N/A |
1,1'-Carbonylbispiperdine | 5395-04-0 | 500 | LDLO | i.p. | mouse | 234 | 10 | 10 | 10 | 10 | 3.50 | 3 | Neg | Neg | N/A |
1,4-Dioxatetradecane-5,14-dione | 5578-82-5 | 4750 | LD50 | oral | mouse | 235 | 10 | 10 | 10 | 10 | 33.3 | 1 | Neg | Neg | N/A |
Irganox 1010 | 6683-19-8 | 3160 | LD50 | dermal | rabbit | 236 | 10 | 10 | 10 | 10 | 22.1 | 2 | Neg | Neg | N/A |
250 | NOEL | oral | dogs | 237 | 10 | 10 | 10 | 1 | 17.5 | ||||||
Terephthalic acid, diethylhexyl ester | 6422-86-2 | 79 | NOEL | oral | rats | 238 | 10 | 10 | 10 | 1 | 5.53 | 1 | Neg | Posc | Neg1 |
3-(4-Hydroxyphenyl)-2-phenol | 7400-08-0 | 50 | TDLO | oral | rats | 239 | 10 | 10 | 10 | 10 | 0.35 | 1 | Neg | Neg | N/A |
2-Hydroxy-2-methylpropiophenone | 7473-98-5 | 824 | LD50 | i.p. | rats | 240 | 10 | 10 | 10 | 10 | 5.77 | 3 | Neg | Neg | N/A |
Metasilicic acid | 7699-41-4 | 234 | LDLO | i.v. | mouse | 241 | 10 | 10 | 1 | 10 | 16.4 | 3 | Neg | Neg | N/A |
Trition X-100 | 9002-93-1 | 1200 | LD50 | i.v. | mouse | 242 | 10 | 10 | 1 | 10 | 84.0 | 2 | Neg | Neg | Neg1 |
Polyvinylpyrrolidone | 9003-39-8 | 1750 | TDLO | i.v. | rats | 243 | 10 | 10 | 1 | 10 | 123 | 3 | Neg | Neg | Neg1 |
Cellulose diacetate | 9035-69-2 | 5000 | NOEL | oral | rats | 244 | 10 | 10 | 10 | 1 | 350 | 1 | Neg | Neg | N/A |
Silicic acid | 10193-36-9 | 100 | LDLO | i.v. | rats | 245 | 10 | 10 | 1 | 10 | 7.00 | 3 | Neg | Neg | N/A |
2-Cyanoacetic acid, 2-methoxyethyl ester | 10258-54-5 | 4300 | LD50 | oral | rats | 246 | 10 | 10 | 10 | 10 | 30.1 | 3 | Neg | Neg | N/A |
2,6-Di-(t-butyl)-4-hydroxy-4-methyl-2,5-cyclohexadien-1-one | 10396-80-2 | 1600 | LD50 | i.p. | mouse | 247 | 10 | 10 | 10 | 10 | 11.2 | 3 | Posg | Neg | N/A |
1,6-Hexanediol diacrylate | 13048-33-4 | 5000 | LD50 | oral | rats | 248 | 10 | 10 | 10 | 10 | 35.0 | 1 | Neg | Neg | Neg1 |
760 | LD50 | i.p. | rats | 249 | 10 | 10 | 10 | 10 | 5.32 | ||||||
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicob | In Vitroa | |||||
A | B | ||||||||||||||
Trimethyolpropane triacrylate | 15625-89-5 | 55 | LD50 | i.p. | rats | 250 | 10 | 10 | 10 | 10 | 0.385 | 1 | Neg | Neg | Pos2 |
2-Heptenoic acid | 18999-28-5 | 1600 | LD50 | i.p. | mouse | 251 | 10 | 10 | 10 | 10 | 11.2 | 1 | Neg | Neg | N/A |
3,5-Bis(1,1-dimethylethyl)-4-hydroxy-benzenepropanoic acid | 20170-32-5 | 2730 | TDLO | oral | rats | 252 | 10 | 10 | 10 | 10 | 19.1 | 2 | Neg | Neg | N/A |
5-(Decahydro-5,5,8-trimethyl-2-methylene-1-napthalenyl)-3-methyl-2-pentenoic acid | 24470-48-2 | 517 | TDLO | dermal | mouse | 253 | 10 | 10 | 10 | 10 | 3.62 | 1 | N/A | N/A | N/A |
Cis-9,10-epoxyoctadecanoic acid | 24560-98-3 | 250 | NOEL | oral | rats | 254 | 10 | 10 | 10 | 1 | 17.5 | 3 | Posd | Neg | N/A |
2,2-Dimethoxy-1,2-diphenyl ethanone | 24650-42-8 | 120 | TDLO | oral | rats | 255 | 10 | 10 | 10 | 10 | 0.84 | 3 | Neg | Neg | N/A |
Polyethylene terephthalate | 25038-59-9 | 3200 | LD50 | oral | rats | 256 | 10 | 10 | 10 | 10 | 22.4 | 3 | Neg | Neg | N/A |
Benzene dicarboxylic acid, diisooctyl ester | 27554-26-3 | 2769 | LD50 | oral | mouse | 257 | 10 | 10 | 10 | 10 | 19.4 | 1 | Neg | Posc | N/A |
2200 | LD50 | oral | rats | 258 | 10 | 10 | 10 | 10 | 15.4 | ||||||
Glyceryl monostearate | 31566-31-1 | 200 | LD50 | i.p. | mouse | 259 | 10 | 10 | 10 | 10 | 1.40 | 1 | Neg | Neg | N/A |
Irgafos 168 | 31570-04-4 | 2000 | LD50 | dermal | rats | 260 | 10 | 10 | 10 | 10 | 14.0 | 3 | Neg | Neg | N/A |
2000 | LD50 | i.p. | rats | 261 | 10 | 10 | 10 | 10 | 14.0 | ||||||
15-Crown-5 | 33100-27-5 | 514 | LD50 | i.p. | mouse | 262 | 10 | 10 | 10 | 10 | 3.60 | 3 | Neg | Neg | Neg1 |
1-Hexadecanol | 36653-82-4 | 1600 | LD50 | i.p. | mouse | 263 | 10 | 10 | 10 | 10 | 11.2 | 1 | Neg | Neg | N/A |
1400 | TDLO | oral | dog | 263 | 10 | 10 | 10 | 10 | 9.80 | ||||||
Tri(propylene glycol) diacrylate | 42978-66-5 | 67 | NOAEL | oral | rats | 264 | 10 | 10 | 10 | 1 | 4.69 | 3 | Neg | Neg | N/A |
2,2,6,6-Tetramethypiperidinol | 52722-86-8 | 2000 | LD50 | oral | rats | 265 | 10 | 10 | 10 | 10 | 14.0 | 3 | Neg | Neg | N/A |
25-Crown-5 | 56890-57-4 | 1.0 | NOAEL | i.v. | rabbit | 266 | 10 | 10 | 1 | 1 | 0.70 | 3 | Neg | Neg | N/A |
Dipropylene glycol diacrylate | 57472-68-1 | 4600 | LD50 | oral | rats | 267 | 10 | 10 | 10 | 10 | 32.2 | 3 | Neg | Neg | N/A |
2-[1-4-Cyano-1,2,3,4-tetrahydronapthyl)]propanenitrile | 57964-39-3 | 441 | LD50 | oral | rats | 268 | 10 | 10 | 10 | 10 | 3.09 | 3 | Neg | Neg | N/A |
3-[1-4-Cyano-1,2,3,4-tetrahydronapthyl)]propanenitrile | 57964-40-6 | 441 | LD50 | oral | rats | 268 | 10 | 10 | 10 | 10 | 3.09 | 3 | Neg | Neg | N/A |
40-Crown-8 | 64001-04-3 | 2.4 | NOEL | i.v. | rabbit | 269 | 10 | 10 | 1 | 1 | 1.68 | 3 | Neg | Neg | N/A |
30-Crown-6 | 64001-05-4 | 0.5 | NOEL | i.v. | rabbit | 269 | 10 | 10 | 1 | 1 | 0.35 | 3 | Neg | Neg | N/A |
Tinuvin 622 | 65447-77-0 | 2000 | LD50 | oral | rats | 276 | 10 | 10 | 10 | 10 | 14.0 | 3 | Neg | Neg | N/A |
Compound | CAS Registry No. | Toxicological Information | Toxicological Uncertainty Factors (UFs) | Risk Index (RI), mg/day | Cramer Class | Carcinogenicity Alerts | |||||||||
Value, mg/kg | Type | Route | Model | Ref. | T1, Inter-species | T2, Intra-species | T3, Route | T4, Type | In Silicob | In Vitroa | |||||
A | B | ||||||||||||||
35-Crown-7 | 66055-34-3 | 0.5 | NOEL | i.v. | rabbit | 269 | 10 | 10 | 1 | 1 | 0.35 | 3 | Neg | Neg | N/A |
Nonylphenol-PEGylated | 68412-54-4 | 3000 | LD50 | oral | rats | 270 | 10 | 10 | 10 | 10 | 21 | 2 | Neg | Neg | N/A |
Alkylphenone | 71868-10-5 | 1800 | LD50 | oral | rats | 271 | 10 | 10 | 10 | 10 | 12.6 | 3 | Neg | Neg | N/A |
Diphenyl-(2,4,6-trimethylbenzoly) phosphine oxide | 75980-60-8 | 300 | TDLO | oral | rats | 272 | 10 | 10 | 10 | 10 | 2.10 | 3 | Neg | Neg | N/A |
Tridecanol/Decanylphenol-PEGylated | 78330-21-9 | 1350 | LD50 | oral | rats | 273 | 10 | 10 | 10 | 10 | 9.45 | 3 | Neg | Neg | N/A |
Atmer 163 | 107043-84-5 | 500 | TDLO | oral | rats | 274 | 10 | 10 | 10 | 10 | 3.50 | 1 | N/A | N/A | N/A |
Polycup 1884 | 129807-53-0 | 2000 | LD50 | oral | rats | 275 | 10 | 10 | 10 | 10 | 14.0 | 3 | N/A | N/A | N/A |
1-Propene-1,2,3-tricarboxylic acid, tributyl ester | 343599-72-4 | 500 | LD50 | i.p. | mouse | 277 | 10 | 10 | 10 | 10 | 3.50 | 1 | Neg | Neg | N/A |
↵a No genotoxocity indicated based on studies in rats, obtained from the Carcinogenic Potency Database (CPDB, 287).
↵b No genotoxicity indicated based on studies in rats and mice, obtained from CPDB (287).
↵c TD50 = 153 mg/kg/day in rats, 565 mg/kg/day in hamster.
↵d From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵e From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵f QSA11 rule triggered, simple aldehyde.
↵g QSA31a rule triggered, halogenated benzene.
h QSA41 rule triggered, substituted n-alkylcarboxylic acids.
↵a No genotoxocity indicated based on studies in rats, obtained from the CPDB (287).
↵b No genotoxicity indicated based on studies in rats and mice, obtained from the CPDB (287).
↵c TD50 = 38.3 mg/kg/day in mice.
↵d TD50 = 1040 mg/kg/day in rats, no effect reported in mice.
↵e TD50 = 3960 mg/kg/day in rats.
↵f TD50 = 232 mg/kg/day in rats, no effect reported in mice.
↵g TD50 = 4350 mg/kg/day in rats.
↵h From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵i From Toxtree (3, 286) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵j QSA8 rule triggered, Aliphatic halogens.
↵k QSA47 rule triggered, o-phenyl phenol.
↵l QSA42 rule triggered, phthalate diesters and monoesters.
↵m QSA41 rule triggered, substituted n-alkyl carboxylic acid.
a No genotoxocity indicated based on studies in either rats, mice or hamsters, obtained from the CPDB (287).
↵b No genotoxicity indicated based on studies in rats and mice, obtained from the CPDB (287).
↵c TD50 = 73 mg/kg/day in rats, 1600 mg/kg/day in mice.
↵d TD50 = 23 mg/kg/day in rats, 210 mg/kg/day in mice.
↵e TD50 = 1490 mg/kg/day in mice, no effect reported in rats.
↵f TD50 = 3880 mg/kg/day in mice, no effect reported in rats.
↵g TD50 = 1680 mg/kg/day in mice, no effect reported rats.
↵h From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵i From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵j QSA11 rule triggered, simple aldehyde.
↵k Potential S. triphimurium TA 100 mutagen; QAA 15 and QSA 27 rules triggered, isocyanate and isothiocyanate groups, primary aromatic amine, hydroxyl amine and its derived esters.
↵l QSA41 rule triggered, substituted n-alkyl carboxylic acid.
a No genotoxocity indicated based on studies in either rats, mice or hamsters, obtained from the CPDB (286).
↵b No genotoxicity indicated based on studies in rats and mice, obtained from the CPDB (286).
↵c TD50 = 17 mg/kg/day in rats, 6.3 mg/kg/day in mice.
d TD50 = 3060 mg/kg/day in rats, no effect reported in mice.
↵e TD50 = 407 mg/kg/day in rats, 1300 mg/kg/day in mice.
↵f From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵g From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵h QSA11 rule triggered, simple aldehyde.
↵i QSA10 rule triggered, α, β-unsaturated carbonyls.
↵j TD50 = 67 mg/kg/day in rats, 24 mg/kg/day in mice.
a No genotoxocity indicated based on studies in either rats, mice or hamsters, obtained from the CPDB (286).
↵b No genotoxicity indicated based on studies in rats and mice, obtained from the CPDB (286).
↵d TD50 = 1660 mg/kg/day in rats, no effect reported in mice.
↵e TD50 = 1710 mg/kg/day in mice, 1300 mg/kg/day in rats.
↵f From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵g From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵h QSA11 rule triggered, simple aldehyde.
a No genotoxocity indicated based on studies in either rats, mice or hamsters, obtained from Carcinogenic Potency Database (286).
↵b No genotoxicity indicated based on studies in rats and mice, obtained from Carcinogenic Potency Database (286).
↵c TD50 = 716 mg/kg/day in rats, 700 mg/kg/day in mice.
↵d From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵e From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵f QSA11 rule triggered, simple aldehyde.
↵g QSA41 and QSA42 rules triggered, substituted n-alkylcarbonic acid, phthalate diesters and monoesters.
↵h QSA42 rule triggered, phthalate diesters and monoesters.
a No genotoxocity indicated based on studies in either rats, mice or hamsters, obtained from Carcinogenic Potency Database (286).
b No genotoxicity indicated based on studies in rats and mice, obtained from Carcinogenic Potency Database (286).
↵c TD50 = 190 mg/kg/day in rats, 1120 mg/kg/day in mice.
↵d TD50 = 653 mg/kg/day in mice, no effect reported in rats.
e TD50 = 344 mg/kg/day in rats, no effect reported in mice.
f From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵g From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
h QSA11 rule triggered, simple aldehyde.
↵i QSA2 rule triggered, alkyl (C5) or benzene ester of sulphonic or phosphoric acid.
↵j QSA42 rule triggered, phthalate diesters and monoesters.
↵k QSA41 rule triggered, substituted or alkylcarboxylic acids.
↵l TD50 =650 mg/kg/day in rats, not tested in mice.
a No genotoxocity indicated based on studies in either rats, mice or hamsters, obtained from Carcinogenic Potency Database (286).
↵b No genotoxicity indicated based on studies in rats and mice, obtained from Carcinogenic Potency Database (286).
↵c QSA12 rule triggered, Quinones.
d TD50 = 2050 mg/kg/day in mice, no effect reported in rats.
↵e From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵f From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵g QSA7 rule triggered, epoxides and aziridines.
↵h QSA8 rule triggered, aliphatic halogens.
↵i QSA11 rule triggered, simple aldehydes.
↵j QSA42 rule triggered, phthalate diesters and monoesters.
↵a From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵b From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
c QSA12 rule triggered, quinines.
↵d QSA10 rule triggered, β-saturated carbonyls.
↵e QSA11 rule triggered, simple aldehydes.
↵f QSA42 triggered, phthalate diesters and monoesters.
↵g ASA7 rule triggered, epoxides and aziridines.
↵h QSA41 and QSA 42 rules triggered, substituted n-alkylcarbonic acid, phthalate diesters and monoesters.
↵i QSA17 rule triggered, thiocarbonyl.
↵a From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵b From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵c QSA41 rule triggered, substituted n-alkylcarboxylic acids.
↵d QSA15 rule triggered, isocynate and isothiocyanate groups.
↵e QSA8 rule triggered, aliphatic halogens.
↵f QSA41 and QSA42 rules triggered, substituted n-alkylcarbonic acid, phthalate diesters and monoesters.
↵g QSA10 rule triggered, α, β-unsaturated carbonyls.
↵a From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵b From Toxtree (3, 286) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.
↵c QSA42 rule triggered, phthalate diesters and monoesters.
↵d QSA7 rule triggered, epoxides and aziridines.
↵a From CCRIS database (287). Neg1 = negative Ames Salmonella typimurium test. Neg2 = negative Ames and Mouse Lymphoma tests. Pos1 = positive Ames or Mouse Lymphoma test. Pos2 = positive Ames and Mouse Lymphoma test. N/A = No test data available for that compound.
↵b From Toxtree (3, 285) using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects.